Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

rhenium Re 188 etidronate

A synthetic compound containing the bisphosphonate etidronate (hydroxyethylidene diphosphonate, HEDP) labeled with rhenium Re188, a beta-emitting radioisotope with potential antineoplastic activity. Upon administration, Re-188 etidronate binds to hydroxyapatite in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. The beta-radiation may provide localized anti-tumor radiotoxicity while sparing extramedullary bone marrow tissues.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:188Re-etidronate
188Re-HEDP
Re 188 etidronic acid
Re 188 hydroxyethylidene diphosphonate
Re-188 etidronate
Re-188 HEDP
Re-188 hydroxyethylidene diphosphonate
Re-188etidronate
rhenium Re 188-HEDP
rhenium Re-188 hydroxyethylidene diphosphonate
rhenium-188 etidronate
rhenium-188 HEDP
rhenium-188-HEDP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search